Butterfly Network, Inc. stands out for its pioneering Ultrasound-on-Chip™ technology embedded in handheld ultrasound devices and related enterprise software. Despite revenue growth and technological advancements, the company has yet to achieve profitability, facing ongoing operating losses that have moderately improved from 2022 through 2025. Significant supply chain dependencies on contract manufacturers and semiconductor suppliers present pricing and production risks, amplified by a complex regulatory environment and ongoing litigation. Strong liquidity cushions these risks, but monitoring operational scale-up and regulatory developments remains crucial to assessing future viability.